Cord Blood Tissue-Derived Mesenchymal Stromal Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cord Blood Tissue-Derived Mesenchymal Stromal Cells, covering 2026-04-17 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease [EARLY_Phase 1]